No Data
No Data
Express News | Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.d., to Its Board of Directors
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to Its Board of Directors
PDF Version REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilim
Express News | Cantor Fitzgerald Reiterates Overweight on Jasper Therapeutics
Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
PDF Version REDWOOD CITY, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel ant
Express News | Jasper Therapeutics Presents Preclinical Briquilimab Study Data At 2024 EHA Hybrid Congress
Jasper Therapeutics Presents Data From Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
PDF Version REDWOOD CITY, Calif., June 14, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilim
No Data